ZHAOWEI Unveils Groundbreaking Dexterous Hand at CES 2025
SHENZHEN, China, Jan. 20, 2025 /PRNewswire/ — CES 2025, held from January 7-10 at the Las Vegas Convention Center, once again solidified its role as the premier global platform for technological innovation, with ZHAOWEI (Shenzhen ZHAOWEI Machinery & Electronics Co., Ltd) making a strong im
Adjust brings two all-new adjustable vapes
mysweet, industry’s first to adjust sweetness mysour unleashes four levels of sourness MIAMI, Jan. 20, 2025 /PRNewswire/ — Adjust, a vaping explorer, unveils mysweet and mysour, two adjustable single-use vapes for a tailored flavor experience in the US. As the latest additions to Adjust
Adjust brings two all-new adjustable vapes
mysweet, industry’s first to adjust sweetness mysour unleashes four levels of sourness MIAMI, Jan. 20, 2025 /PRNewswire/ — Adjust, a vaping explorer, unveils mysweet and mysour, two adjustable single-use vapes for a tailored flavor experience in the US. As the latest additions to Adjust
JELD-WEN Completes Sale of Towanda, PA Facility as a Result of Court-Ordered Divestiture Process
CHARLOTTE, N.C., Jan. 20, 2025 /PRNewswire/ — JELD-WEN Holding, Inc. (NYSE: JELD) (“JELD-WEN” or the “Company”), a leading global manufacturer of building products, today announced that, in compliance with the court-ordered divestiture of its Towanda, Pennsylvania busin
JELD-WEN Completes Sale of Towanda, PA Facility as a Result of Court-Ordered Divestiture Process
CHARLOTTE, N.C., Jan. 20, 2025 /PRNewswire/ — JELD-WEN Holding, Inc. (NYSE: JELD) (“JELD-WEN” or the “Company”), a leading global manufacturer of building products, today announced that, in compliance with the court-ordered divestiture of its Towanda, Pennsylvania busin
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 20, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 20, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive
Health Canada Authorizes Vabysmo® (faricimab injection) Pre-Filled Syringe (PFS) for Three Leading Causes of Vision Loss
Vabysmo PFS is the first and only syringe prefilled with a Health-Canada approved bispecific antibody to treat retinal conditions that can cause blindness1 Designed to simplify administration, Vabysmo PFS provides retina specialists with a ready-to-use option Vabysmo PFS will be available for people
MD Financial Management Inc. introduces a limited-time[1] private real estate solution for physicians and their families
MD Financial Management Inc. (MD) today announced the expansion of its investment platform with the introduction of the MD Platinum™ Global Private Real Estate 2025 Trust, the fifth MD Platinum™ product and the second MD Platinum™ private real estate offering. OTTAWA, ON, Jan. 20, 2025 /CNW/
Pyramid Consulting, Inc. Partners with Dynatrace to Provide Unified Observability, AIOps, and Application Security
ATLANTA, Jan. 20, 2025 /PRNewswire/ — Pyramid Consulting, Inc., a global leader in workforce and technology solutions, announces a transformative partnership with Dynatrace (NYSE: DT). The partnership establishes Pyramid Consulting, Inc., and its technology division, Celsior, as a premier Glo